Stock ANEB ANEBULO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Anebulo Pharmaceuticals, Inc.

Equities

ANEB

US0345691036

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-28 pm EDT 		5-day change 1st Jan Change
2.08 USD -1.65% Intraday chart for Anebulo Pharmaceuticals, Inc. -1.42% -14.05%
May. 15 Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
Feb. 13 Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates
BU
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates
BU
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates
BU
Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors
AQ
Anebulo Pharmaceuticals Announces New CEO
AQ
Anebulo Pharmaceuticals Announces New CEO
BU
Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors
BU
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates
BU
Anebulo Pharmaceuticals : Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates - Form 8-K
PU
Anebulo Pharmaceuticals to Present at Upcoming Investor and Scientific Conferences
BU
Anebulo Pharmaceuticals : Corporate Presentation August 2023
PU
Anebulo Receives Positive Feedback from FDA on Path to Advance Phase 3 Clinical Development of ANEB-001 and Completes Dosing of Phase 2 Extension
BU
ANEBULO PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
AQ
Anebulo Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Recent Updates
PR
ANEBULO PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
ANEBULO PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Anebulo Pharmaceuticals Announces Positive Complete Phase 2 Clinical Data Demonstrating Potential of ANEB-001 as a Treatment for Acute Cannabinoid Intoxication
PR
ANEBULO PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Anebulo Pharmaceuticals Expands its Integrated and Outsourced Solutions
PR
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2023 Financial Results and Recent Updates
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANEB Stock
  4. News Anebulo Pharmaceuticals, Inc.
  5. Press Releases